Related Experiment Video
Updated: Jul 31, 2025

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Dorzolamide suppresses PKCδ -TIRAP-p38 MAPK signaling axis to dampen the inflammatory response
Sajjan Rajpoot1, Ashutosh Kumar2, Vadim Gaponenko3
1Department of Biosciences & Biomedical Engineering, Indian Institute of Technology Indore, Simrol, Indore, 453552, India.
Abstract:
Background: Sepsis is a syndrome due to microbial infection causing impaired multiorgan function. Its underlying cause is immune dysfunction and macrophages play an essential role. Methods: TIRAP interaction with PKCδ in macrophage was studied, revealing downstream signaling by Western blot and quantitative reverse transcriptase PCR. Dorzolamide (DZD) disrupting TIRAP-PKCδ interaction was identified by virtual screening and validated in vitro and in septic mice. Results: The study highlights the indispensable role of TIRAP-PKCδ in p38 MAPK-activation, NF-κB- and AP-1-mediated proinflammatory cytokines expression, whereas DZD significantly attenuated the signaling. Conclusion: Targeting TIRAP-PKCδ interaction by DZD is a novel therapeutic approach for treating sepsis.
Insights
Dorzolamide (DZD) disrupts the TIRAP-PKCδ interaction, a key pathway in sepsis immune dysfunction. This novel approach effectively reduces sepsis-related inflammation and organ impairment in mice.
Area of Science:
- Immunology
- Molecular Biology
- Pharmacology
Background:
- Sepsis is a life-threatening condition characterized by dysregulated immune responses and organ dysfunction.
- Macrophages are critical immune cells involved in the pathogenesis of sepsis.
- Immune dysfunction in sepsis involves complex molecular signaling pathways.
Purpose of the Study:
- To investigate the role of TIRAP-PKCδ interaction in macrophage activation during sepsis.
- To identify and validate a therapeutic agent targeting the TIRAP-PKCδ interaction.
Main Methods:
- Studied TIRAP-PKCδ interaction and downstream signaling in macrophages using Western blot and qRT-PCR.
- Employed virtual screening to identify Dorzolamide (DZD) as an inhibitor of TIRAP-PKCδ interaction.
- Validated DZD efficacy in vitro and in a mouse model of sepsis.
Main Results:
- TIRAP-PKCδ interaction is essential for p38 MAPK activation and the expression of proinflammatory cytokines via NF-κB and AP-1.
- Dorzolamide (DZD) significantly inhibited these sepsis-associated signaling pathways.
- DZD treatment attenuated sepsis-induced inflammation and organ dysfunction in vivo.
Conclusions:
- Targeting the TIRAP-PKCδ interaction represents a novel therapeutic strategy for sepsis.
- Dorzolamide (DZD) shows promise as a potential treatment for sepsis by modulating key inflammatory pathways.
More Related Videos
Related Concept Videos
MAPK Signaling Cascades
GPCR Desensitization
PI3K/mTOR/AKT Signaling Pathway
IP3/DAG Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Desensitization and Tachyphylaxis

